FOV-2501

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameFOV-2501
Drug Alias NameFOV-2501
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionNucleoredoxin-like protein 1 stimulants
TargetsNucleoredoxin-like protein 1
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFovea Pharmaceuticals Sa
Active IndicationsN/A
Inactive IndicationsRetinitis Pigmentosa

Other Information

ATC CodeN/A
Related LinksN/A